612 related articles for article (PubMed ID: 17603936)
1. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
Qin F; Simeone M; Patel R
Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
[TBL] [Abstract][Full Text] [Related]
2. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
3. Activation of NADPH oxidase mediates increased endoplasmic reticulum stress and left ventricular remodeling after myocardial infarction in rabbits.
Li B; Tian J; Sun Y; Xu TR; Chi RF; Zhang XL; Hu XL; Zhang YA; Qin FZ; Zhang WF
Biochim Biophys Acta; 2015 May; 1852(5):805-15. PubMed ID: 25615792
[TBL] [Abstract][Full Text] [Related]
4. Vitamins C and E attenuate apoptosis, beta-adrenergic receptor desensitization, and sarcoplasmic reticular Ca2+ ATPase downregulation after myocardial infarction.
Qin F; Yan C; Patel R; Liu W; Dong E
Free Radic Biol Med; 2006 May; 40(10):1827-42. PubMed ID: 16678021
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin.
Qin F; Patel R; Yan C; Liu W
Free Radic Biol Med; 2006 Jan; 40(2):236-46. PubMed ID: 16413406
[TBL] [Abstract][Full Text] [Related]
6. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
Wang S; Fei K; Xu YW; Wang LX; Chen YQ
Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
[TBL] [Abstract][Full Text] [Related]
7. The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure.
Wang K; Zhu ZF; Chi RF; Li Q; Yang ZJ; Jie X; Hu XL; Han XB; Wang JP; Li B; Qin FZ; Fan B
Exp Physiol; 2019 Nov; 104(11):1638-1649. PubMed ID: 31475749
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction.
Isabelle M; Vergeade A; Moritz F; Dautréaux B; Henry JP; Lallemand F; Richard V; Mulder P; Thuillez C; Monteil C
J Mol Cell Cardiol; 2007 Feb; 42(2):326-32. PubMed ID: 17217956
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
11. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
12. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
13. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.
Bauersachs J; Hiss K; Fraccarollo D; Laufs U; Ruetten H
Cardiovasc Res; 2006 Dec; 72(3):438-46. PubMed ID: 17026973
[TBL] [Abstract][Full Text] [Related]
15. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Morimoto H; Hirose M; Takahashi M; Kawaguchi M; Ise H; Kolattukudy PE; Yamada M; Ikeda U
Cardiovasc Res; 2008 Jun; 78(3):554-62. PubMed ID: 18267955
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart.
Gupte RS; Vijay V; Marks B; Levine RJ; Sabbah HN; Wolin MS; Recchia FA; Gupte SA
J Card Fail; 2007 Aug; 13(6):497-506. PubMed ID: 17675065
[TBL] [Abstract][Full Text] [Related]
19. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin preconditioning of the heart: evidence for redox signaling.
Das S; Engelman RM; Maulik N; Das DK
Cell Biochem Biophys; 2006; 44(1):103-10. PubMed ID: 16456238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
